102 related articles for article (PubMed ID: 21893488)
1. Normal chest radiograph and ground glass opacities on a thoracic computed tomographic scan in a patient with diffuse alveolar haemorrhage due to dual antiplatelet therapy prescribed after patent foramen ovale percutaneous device closure.
Kalinczuk L; Lubiszewska B; Demkow M
Eur Heart J; 2011 Dec; 32(23):2988. PubMed ID: 21893488
[No Abstract] [Full Text] [Related]
2. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome.
Ikeda M; Tanaka H; Sadamatsu K
Cardiovasc Revasc Med; 2011; 12(6):407-11. PubMed ID: 21514251
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction.
Oualim S; Elharda CA; Benzeroual D; Hattaoui ME
Pan Afr Med J; 2016; 24():308. PubMed ID: 28154663
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
[TBL] [Abstract][Full Text] [Related]
5. Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjöstrand C; Roine RO; Hildick-Smith D; Spence JD; Søndergaard L;
N Engl J Med; 2021 Mar; 384(10):970-971. PubMed ID: 33704944
[No Abstract] [Full Text] [Related]
6. Haemorrhage associated with combined clopidogrel and aspirin therapy.
Chapman TW; Bowley DM; Lambert AW; Walker AJ; Ashley SA; Wilkins DC
Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):478-9. PubMed ID: 11735194
[No Abstract] [Full Text] [Related]
7. Patent foramen ovale closure and brain ischaemic lesions.
Ammirati E; Comi G; Camici PG
Heart; 2013 Oct; 99(20):1543. PubMed ID: 23872593
[No Abstract] [Full Text] [Related]
8. Spontaneous chest wall hematoma with dual antiplatelet therapy.
Bevan P; Menon A; Bunton R
Can J Cardiol; 2014 Feb; 30(2):247.e1-2. PubMed ID: 24290862
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
10. Transhepatic closure of patent foramen ovale.
Jolly N; Dhar G; Amin Z
Catheter Cardiovasc Interv; 2010 Jan; 75(1):56-9. PubMed ID: 19642189
[TBL] [Abstract][Full Text] [Related]
11. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
Patti G; Pelliccia F; Gaudio C; Greco C
Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037
[TBL] [Abstract][Full Text] [Related]
13. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
[No Abstract] [Full Text] [Related]
14. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
Roth C; Alli O
Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
[TBL] [Abstract][Full Text] [Related]
15. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
16. Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
Meier B
Catheter Cardiovasc Interv; 2009 Oct; 74(4):652. PubMed ID: 19780059
[No Abstract] [Full Text] [Related]
17. Perioperative hemorrhage and combined clopidogrel and aspirin therapy.
Moore M; Power M
Anesthesiology; 2004 Sep; 101(3):792-4. PubMed ID: 15329606
[No Abstract] [Full Text] [Related]
18. Late thrombus formation on the Helex septal occluder after double-lung transplant.
Zaidi AN; Cheatham JP; Galantowicz M; Astor T; Kovalchin JP
J Heart Lung Transplant; 2010 Jul; 29(7):814-6. PubMed ID: 20382035
[TBL] [Abstract][Full Text] [Related]
19. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
[TBL] [Abstract][Full Text] [Related]
20. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
Korabathina R; Thaler DE; Kimmelstiel C
Catheter Cardiovasc Interv; 2012 Sep; 80(3):498-502. PubMed ID: 21953702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
